Market Research Logo

Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review

Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review

provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Auris Medical Holding AG (Auris Medical) is a clinical-stage biopharmaceutical company that develops therapeutics to address unmet medical needs in the area of otolaryngology. The company’s pipeline encompasses investigational candidates targeted at the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, sudden loss of hearing, and Meniere’s disease (Vertigo). Auris Medical also carries out research to advance various early-stage development projects in the area of rhinology. It works in collaboration with various research and development institutions and pharmaceutical and biotechnology companies. Auris Medical is headquartered in Zug, Switzerland.

Auris Medical Holding AG Key Recent Developments

Aug 15,2018: Auris Medical announces second quarter 2018 financial results
Jul 12,2018: Auris Medical Prices $7 Million Public Offering
May 15,2018: Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results
Apr 09,2018: Auris Medical Announces Early Repayment of Part of its Loan Facility
Mar 22,2018: Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Auris Medical Holding AG - Key Facts
Auris Medical Holding AG - Key Employees
Auris Medical Holding AG - Key Employee Biographies
Auris Medical Holding AG - Major Products and Services
Auris Medical Holding AG - History
Auris Medical Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Auris Medical Holding AG - Business Description
R&D Overview
Auris Medical Holding AG - SWOT Analysis
SWOT Analysis - Overview
Auris Medical Holding AG - Strengths
Auris Medical Holding AG - Weaknesses
Auris Medical Holding AG - Opportunities
Auris Medical Holding AG - Threats
Auris Medical Holding AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Auris Medical Holding AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 12, 2018: Auris Medical Prices $7 Million Public Offering
May 15, 2018: Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results
Apr 09, 2018: Auris Medical Announces Early Repayment of Part of its Loan Facility
Mar 22, 2018: Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 16, 2018: Auris’ tinnitus treatment fails late-stage study for the second time
Dec 28, 2017: Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018
Nov 28, 2017: Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update
Sep 26, 2017: Auris Medical Provides Board of Directors Update
Aug 10, 2017: Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results
May 31, 2017: Auris Medical to Host Key Opinion Leader Event Focused on Clinical-Stage Pipeline on June 16 in New York City
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Auris Medical Holding AG, Key Facts
Auris Medical Holding AG, Key Employees
Auris Medical Holding AG, Key Employee Biographies
Auris Medical Holding AG, Major Products and Services
Auris Medical Holding AG, History
Auris Medical Holding AG, Subsidiaries
Auris Medical Holding AG, Key Competitors
Auris Medical Holding AG, Ratios based on current share price
Auris Medical Holding AG, Annual Ratios
Auris Medical Holding AG, Annual Ratios (Cont...1)
Auris Medical Holding AG, Interim Ratios
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Auris Medical Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Auris Medical Holding AG, Performance Chart (2013 - 2017)
Auris Medical Holding AG, Ratio Charts
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report